Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06241209
Other study ID # 00134526
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 25, 2024
Est. completion date December 15, 2028

Study information

Verified date January 2024
Source University of Alberta
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In patients with hemianopsia following stroke or brain injury, we will determine if stimulating the visual field with images from a PowerPoint slide set can increase the visual field.


Description:

Purpose: To determine if a computer screen visual stimulation can improve peripheral field loss in patients with vision pathway brain injury. Hypothesis: Visual stimulation helps patients with visual pathway brain injury recover peripheral vision. Justification: i) Axonal sprouting or re-rerouting can occur after brain injury ii) In Canada stroke prevalence comprises almost 900,000 patients. (Canada.ca, Health 2022). It is estimated that half of stroke survivors have a visual field deficit. (Rowe et al, PLoS One. 2019). There is clinical equipoise regarding the results of vision therapy with visual stimulation. Romano JG, et al. Journal of the Neurological Sciences. 2008 Oct 15;273(1-2):70-4. versus Horton JC. Disappointing results from Nova Vision's visual restoration therapy. British Journal of Ophthalmology. 2005 Objectives: To determine the effect size of visual recovery, if any with computer screen visual stimulation Research Method/Procedures The project is prospective. Patients undergoing visual field testing found to have a hemianopsia will be invited to participate in the study. Chart review will be conducted on Connect Care. The following information will be collected: Patient age, sex, hand dominance, location and extent of stroke, number of prior strokes, time since initial/last stroke, neurologic diagnosis of neglect, perimetric findings, hours of television viewing, hours of smart phone use, hours of playing video games, smoking history, hypertension, diabetes mellitus, and hyperlipidemia. Group 1 with an odd number year of birth will be asked to view 15 minutes of online news three days per week for 2 months. LIVE: Canadian News | Weather & Traffic - Latest Sports | Breaking News (globalnews.ca) Group 2 with an even number year of birth will be asked to view the 15-minute PowerPoint program three days per week for 2 months. At the end of 2 months, the study groups will be asked to cross over for 2 months, and perimetry will be repeated at month 4 from study entry. If patients originally in Group 2 do not want to stop using the PowerPoint program, they will be allowed to drop out of the study. A 24-degree Humphrey automated perimetry will be performed at study entry, month two and month four. The perimeter provides a visual field index (VFI) with scores ranging from zero (no perceived light) to 100 (normal). PLAN FOR DATA ANALYSIS: For each patient, the VFI from both eyes will be averaged. The difference between the pre-intervention and post-intervention VFI's will be compared between the PowerPoint intervention versus observation groups after 2 months. The same analysis will be repeated after the cross-over.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 15, 2028
Est. primary completion date December 15, 2027
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: All patients 18 years of age or older with a homonymous hemianopsia or quadrantopsia, who can provide informed consent, and communicate in English. Exclusion Criteria: - The flashing lights from thge automated perimeter and PowerPoint program can potentially trigger photic seizures. Therefore patients with light-induced seizures are excluded.

Study Design


Intervention

Other:
PowerPoint program visual stimulation
Moving objects, food, money, and other targets will be presented in the remaining seeing, and hemianopic areas.

Locations

Country Name City State
Canada Eye Institute of Alberta, Royal Alexandra Hospital Edmonton Alberta

Sponsors (1)

Lead Sponsor Collaborator
University of Alberta

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Field Index on Humphrey perimetry (100 is an intact field) 2 months
See also
  Status Clinical Trial Phase
Recruiting NCT06000865 - Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE N/A
Recruiting NCT05619432 - Re:Garde Program - Training and Maintaining Visual Perception in Older Adults N/A
Completed NCT03670303 - Trial of an Educational Intervention to Promote Spectacle Use Among Secondary School Children in Islamabad, Pakistan N/A
Completed NCT02896738 - MRI Screening for Auditory Pathway Malformations in Visually Impaired Children
Completed NCT01822717 - Nonvisual Foot Inspection for People With Visual Imapirment N/A
Completed NCT03865134 - Evaluation of Visual - Motor Development in Children With Retinopathy of Prematurity
Active, not recruiting NCT04198350 - Pancreatic Islet Transplantation to the Anterior Chamber of the Eye N/A
Recruiting NCT05220449 - Re-Orchestration of Interregional Oscillatory Activity to Promote Visual Recovery N/A
Completed NCT04190147 - Eye and Growth in Adolescents Born Moderate-to-late Preterm
Completed NCT05135195 - A Virtual Reality Platform Simulating Visual Impairment for Testing of Electronic Travel Aids and Performing Orientation and Mobility Training N/A
Recruiting NCT05199363 - Pediatric Patient Experience on a Diagnostic Path N/A
Active, not recruiting NCT03767803 - Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Recruiting NCT03571217 - Shanghai Beixinjing Diabetic Eyes Study
Not yet recruiting NCT03726606 - A Comparison of the Visual Performance of Trifocal Versus Extended Depth of Focus Intraocular Lenses N/A
Completed NCT02259088 - A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients Phase 3
Completed NCT06197607 - Effect of Hand Exercises on Hand Grip Strength and Manual Ability in Children With Visual Impairment N/A
Withdrawn NCT04579653 - Pupillometry and Locus Coeruleus Activation (PuLCA) N/A
Recruiting NCT05844982 - Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy Phase 3
Recruiting NCT02258113 - Measuring of Neuro-visual Functionality With Ocusweep N/A
Completed NCT02607384 - The Baltimore Reading and Eye Disease Study N/A

External Links